Invention Grant
- Patent Title: Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
- Patent Title (中): 可用于治疗退行性和炎性疾病的三唑并吡嗪化合物
-
Application No.: US11809294Application Date: 2007-05-30
-
Publication No.: US07501411B2Publication Date: 2009-03-10
- Inventor: Martin James Inglis Andrews , Paul Edwards , Mark Stuart Chambers , Wolfgang Schmidt , Juha Andrew Clase , Gregory Bar , Kim Louise Hirst , Angus MacLeod
- Applicant: Martin James Inglis Andrews , Paul Edwards , Mark Stuart Chambers , Wolfgang Schmidt , Juha Andrew Clase , Gregory Bar , Kim Louise Hirst , Angus MacLeod
- Applicant Address: BE Mechelen
- Assignee: Galapagos, NV
- Current Assignee: Galapagos, NV
- Current Assignee Address: BE Mechelen
- Agency: Klauber & Jackson L.L.C.
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/4985
Abstract:
Novel [1.2.4]triazolo[1,5-a]pyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, and others.
Public/Granted literature
- US20080090818A1 Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases Public/Granted day:2008-04-17
Information query
